Actavis PLC (NYSE:ACT)

297.05
Delayed Data
As of Apr 17
 +0.60 / +0.20%
Today’s Change
193.00
Today|||52-Week Range
317.72
+15.40%
Year-to-Date

Today’s Trading

Previous close296.45
Today’s open294.30
Day’s range291.74 - 297.05
Volume2,839,567
Average volume (3 months)3,343,065
Market cap$120.3B
Dividend yield--
Data as of 4:05pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+25.29%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.79

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.29-0.61%
NVONovo Nordisk-0.20-0.36%
BMYBristol-Myers Squibb+1.67+2.62%
SNYSanofi-0.46-0.88%
Data as of 4:07pm ET, 04/17/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)$3.97
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers